Treatment of multiple sclerosis with interferon β(1b)

S. Dhib-Jalbut, H. F. McFarland

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Interferon β(1b) is now an established therapeutic option for relapsing remitting multiple sclerosis. More recently, it has also been shown to slow down disease progression in secondary progressive multiple sclerosis. Interferon β(1b)'s clinical effect is reflected in MRI studies demonstrating a dramatic effect in reducing disease activity. The drug is generally well tolerated, but its efficacy can be compromised in some patients by the emergence of neutralizing antibodies. This chapter will focus on interferon β(1b) (Betaseron) treatment for multiple sclerosis, its clinical and MRI effects, and its putative mechanism of action.

Original languageEnglish (US)
Pages (from-to)467-480
Number of pages14
JournalBailliere's Clinical Neurology
Issue number3
StatePublished - 1997
Externally publishedYes


  • Betaseron
  • Interferon β(1b)
  • Multiple sclerosis

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Treatment of multiple sclerosis with interferon β(1b)'. Together they form a unique fingerprint.

Cite this